At the end of May 2017, CSL Behring and Unico organised scientific symposiums in Hanoi and Ho Chi Minh city to present the first launch of a subcutaneous immunoglobulin replacement therapy in Vietnam and update the information and treatment options for PIDD. Many doctors in Department of Immunology and Pediatrics throughout Vietnam have been interested in and participated.
